We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Krystal Biotech
KRYS
$10.7B
| $996K | ﹤0.01% |
5,600
-65,301
| -92% | -$9.07M |
|
1627
Edgewise Therapeutics
EWTX
$4.34B
| $996K | ﹤0.01% |
+54,617
| New | +$868K |
|
1628
Public Service Enterprise Group
PEG
$39.3B
| $995K | ﹤0.01% |
14,900
-84,074
| -85% | -$5.15M |
|
1629
Lufax Holding
LU
$1.33B
| $994K | ﹤0.01% |
235,569
-1,142,400
| -83% | -$3.2M |
|
1630
Capital Group International Focus Equity ETF
CGXU
$6.15B
| $993K | ﹤0.01% |
+38,535
| New | +$944K |
|
1631
NewtekOne
NEWT
$425M
| $991K | ﹤0.01% |
90,081
+75,286
| +509% | +$887K |
|
|
ATXS
1632
DELISTED
Astria Therapeutics
ATXS
| $989K | ﹤0.01% |
70,241
+55,941
| +391% | +$697K |
|
1633
Viant Technology
DSP
$227M
| $988K | ﹤0.01% |
92,684
+8,840
| +11% | +$77K |
|
1634
Beazer Homes USA
BZH
$913M
| $987K | ﹤0.01% |
30,103
-81,933
| -73% | -$2.53M |
|
|
BDN
1635
Brandywine Realty Trust
BDN
$521M
| $987K | ﹤0.01% |
+205,631
| New | +$953K |
|
1636
Red Robin
RRGB
$139M
| $977K | ﹤0.01% |
+127,587
| New | +$1.17M |
|
1637
ATN International
ATNI
$370M
| $972K | ﹤0.01% |
+30,858
| New | +$1.08M |
|
1638
Autohome
ATHM
$2.65B
| $969K | ﹤0.01% |
36,940
-54,776
| -60% | -$1.42M |
|
1639
SharkNinja
SN
$22.6B
| $967K | ﹤0.01% |
15,529
-226,805
| -94% | -$12M |
|
1640
Relmada Therapeutics
RLMD
$549M
| $967K | ﹤0.01% |
207,870
+54,345
| +35% | +$262K |
|
1641
Globe Life
GL
$13.9B
| $966K | ﹤0.01% |
+8,300
| New | +$1.02M |
|
|
BSLKW
1642
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
| $960K | ﹤0.01% |
86,603
| – | – |
|
1643
Franklin Covey
FC
$248M
| $960K | ﹤0.01% |
24,457
+11,136
| +84% | +$444K |
|
1644
Nu Holdings
NU
$70.9B
| $957K | ﹤0.01% |
80,219
-16,291,376
| -100% | -$166M |
|
1645
Rigetti Computing
RGTI
$4.83B
| $955K | ﹤0.01% |
624,034
+180,877
| +41% | +$261K |
|
1646
Boise Cascade
BCC
$2.83B
| $952K | ﹤0.01% |
+6,206
| New | +$838K |
|
1647
Vertex
VERX
$2.14B
| $952K | ﹤0.01% |
+29,961
| New | +$808K |
|
1648
Oceaneering
OII
$4.78B
| $951K | ﹤0.01% |
+40,662
| New | +$853K |
|
|
HIBB
1649
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $951K | ﹤0.01% |
12,379
-155,383
| -93% | -$11.1M |
|
|
AGTI
1650
DELISTED
Agiliti Inc
AGTI
| $950K | ﹤0.01% |
93,900
+46,563
| +98% | +$390K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.